From Bench, to Bedside, to Boardroom @NUFeinbergMed
From Bench, to Bedside, to Boardroom  @NUFeinbergMed
Uploaded May 2025 | Updated November 2026, 2 days ago
Priya Kumthekar, MD, didn’t have industry connections or commercialization training when she started working with small companies to help bring scientific advancements to her patients with brain tumors. She learned along the way the many steps it takes to bring new scientific breakthroughs to the marketplace specifically through clinical trials. In this episode, Kumthekar explains how she is now helping to streamline this commercialization process with The Chicago Biomedical Consortium Hub for Innovative Technology and Entrepreneurship in the Sciences (CBC-HITES) where she serves as a clinical trial translation guide and how NUCATS members and investigators from across Chicagoland universities and colleges can benefit from funding and training offered by the program.
From Bench, to Bedside, to BoardroomBioethical Controversies in Crisis Standards of Care: Preparing for the next disaster2024 Tripartite Award Winner: Alan Hauser, MD, PhDPunishing Illness in an Age of Criminal Legal ReformThe Therapeutic Potential of PsychedelicsThe Art and Science of Bedside Medicine with Brian Garibaldi, MDDISCOVERY: New Biomarker for Vascular Aging and Neurodegeneration #AgingResearch #VascularAgingEmerging Drug Targets in Parkinsons Disease with Joe Mazzulli, PhDApplying Implementation Science to Advance Public HealthMedical School Research: New Genes Implicated in Uterine Fibroid DevelopmentCan a Single Session Impact Mental Health for Teens? with Jessica Schleider, PhDThe Future of Fentanyl Dynamics in Supply, Uses, and Consequences
Northwestern Univ. Feinberg School of Medicine |

From Bench, to Bedside, to Boardroom

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER